Belimumab for refractory manifestations of cutaneous lupus: A multicenter, retrospective observational study of 16 patients
Gespeichert in:
Veröffentlicht in: | Journal of the American Academy of Dermatology 2020-12, Vol.83 (6), p.1816-1819 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1819 |
---|---|
container_issue | 6 |
container_start_page | 1816 |
container_title | Journal of the American Academy of Dermatology |
container_volume | 83 |
creator | Salle, Romain Chasset, François Kottler, Diane Picard-Dahan, Catherine Jannic, Arnaud Mekki, Nour De Risi-Pugliese, Tullia Monfort, Jean-Benoît Barbaud, Annick Francès, Camille Descamps, Vincent |
description | |
doi_str_mv | 10.1016/j.jaad.2020.05.058 |
format | Article |
fullrecord | <record><control><sourceid>elsevier_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03492590v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0190962220309233</els_id><sourcerecordid>S0190962220309233</sourcerecordid><originalsourceid>FETCH-LOGICAL-c500t-254690d2129d39658f1f7555d3837c6ce6eb2eace692f5956e4fcd6ccff7af8c3</originalsourceid><addsrcrecordid>eNp9kMGKFDEQhoMo7rj6Ah4kV8EeK0kn3REv46KuMOBFzyGTrmCG7kmTpAeGfXnTju5RKCgo_u-H-gh5zWDLgKn3x-3R2mHLgcMWZJ3-Cdkw0F2jur57SjbANDRacX5DXuR8BADdiu45uRG8FbpVYkMePuEYpmWyB-pjogl9sq7EdKGTPQWPudgS4inT6Klbij1hXDIdl3nJH-iOTstYgsNTwfSuwiXFPKMr4Yw0HjKm8x_ajjSXZbisJUzRuR4rkl-SZ96OGV_93bfk55fPP-7um_33r9_udvvGSYDScNkqDQNnXA9CK9l75jsp5SB60TnlUOGBo61bcy-1VNh6NyjnvO-s7524JW-vvb_saOYUJpsuJtpg7nd7s95AtJpLDWdWs_yadfWVXHU8AgzMat0czWrdrNYNyDp9hd5coXk5TDg8Iv8018DHawDrm-eAyWRXFTgcQqq6zBDD__p_A-XeleM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Belimumab for refractory manifestations of cutaneous lupus: A multicenter, retrospective observational study of 16 patients</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Salle, Romain ; Chasset, François ; Kottler, Diane ; Picard-Dahan, Catherine ; Jannic, Arnaud ; Mekki, Nour ; De Risi-Pugliese, Tullia ; Monfort, Jean-Benoît ; Barbaud, Annick ; Francès, Camille ; Descamps, Vincent</creator><creatorcontrib>Salle, Romain ; Chasset, François ; Kottler, Diane ; Picard-Dahan, Catherine ; Jannic, Arnaud ; Mekki, Nour ; De Risi-Pugliese, Tullia ; Monfort, Jean-Benoît ; Barbaud, Annick ; Francès, Camille ; Descamps, Vincent</creatorcontrib><identifier>ISSN: 0190-9622</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2020.05.058</identifier><identifier>PMID: 32439463</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Antibodies, Monoclonal, Humanized - pharmacology ; Antibodies, Monoclonal, Humanized - therapeutic use ; Drug Resistance ; Female ; Humans ; Immunosuppressive Agents - pharmacology ; Immunosuppressive Agents - therapeutic use ; Life Sciences ; Lupus Erythematosus, Cutaneous - diagnosis ; Lupus Erythematosus, Cutaneous - drug therapy ; Lupus Erythematosus, Cutaneous - immunology ; Male ; Middle Aged ; Retrospective Studies ; Severity of Illness Index ; Treatment Outcome ; Young Adult</subject><ispartof>Journal of the American Academy of Dermatology, 2020-12, Vol.83 (6), p.1816-1819</ispartof><rights>2020 American Academy of Dermatology, Inc.</rights><rights>Attribution - NonCommercial</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c500t-254690d2129d39658f1f7555d3837c6ce6eb2eace692f5956e4fcd6ccff7af8c3</citedby><cites>FETCH-LOGICAL-c500t-254690d2129d39658f1f7555d3837c6ce6eb2eace692f5956e4fcd6ccff7af8c3</cites><orcidid>0000-0001-6043-6242</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0190962220309233$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32439463$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03492590$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Salle, Romain</creatorcontrib><creatorcontrib>Chasset, François</creatorcontrib><creatorcontrib>Kottler, Diane</creatorcontrib><creatorcontrib>Picard-Dahan, Catherine</creatorcontrib><creatorcontrib>Jannic, Arnaud</creatorcontrib><creatorcontrib>Mekki, Nour</creatorcontrib><creatorcontrib>De Risi-Pugliese, Tullia</creatorcontrib><creatorcontrib>Monfort, Jean-Benoît</creatorcontrib><creatorcontrib>Barbaud, Annick</creatorcontrib><creatorcontrib>Francès, Camille</creatorcontrib><creatorcontrib>Descamps, Vincent</creatorcontrib><title>Belimumab for refractory manifestations of cutaneous lupus: A multicenter, retrospective observational study of 16 patients</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><subject>Adult</subject><subject>Aged</subject><subject>Antibodies, Monoclonal, Humanized - pharmacology</subject><subject>Antibodies, Monoclonal, Humanized - therapeutic use</subject><subject>Drug Resistance</subject><subject>Female</subject><subject>Humans</subject><subject>Immunosuppressive Agents - pharmacology</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Life Sciences</subject><subject>Lupus Erythematosus, Cutaneous - diagnosis</subject><subject>Lupus Erythematosus, Cutaneous - drug therapy</subject><subject>Lupus Erythematosus, Cutaneous - immunology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Severity of Illness Index</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>0190-9622</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMGKFDEQhoMo7rj6Ah4kV8EeK0kn3REv46KuMOBFzyGTrmCG7kmTpAeGfXnTju5RKCgo_u-H-gh5zWDLgKn3x-3R2mHLgcMWZJ3-Cdkw0F2jur57SjbANDRacX5DXuR8BADdiu45uRG8FbpVYkMePuEYpmWyB-pjogl9sq7EdKGTPQWPudgS4inT6Klbij1hXDIdl3nJH-iOTstYgsNTwfSuwiXFPKMr4Yw0HjKm8x_ajjSXZbisJUzRuR4rkl-SZ96OGV_93bfk55fPP-7um_33r9_udvvGSYDScNkqDQNnXA9CK9l75jsp5SB60TnlUOGBo61bcy-1VNh6NyjnvO-s7524JW-vvb_saOYUJpsuJtpg7nd7s95AtJpLDWdWs_yadfWVXHU8AgzMat0czWrdrNYNyDp9hd5coXk5TDg8Iv8018DHawDrm-eAyWRXFTgcQqq6zBDD__p_A-XeleM</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Salle, Romain</creator><creator>Chasset, François</creator><creator>Kottler, Diane</creator><creator>Picard-Dahan, Catherine</creator><creator>Jannic, Arnaud</creator><creator>Mekki, Nour</creator><creator>De Risi-Pugliese, Tullia</creator><creator>Monfort, Jean-Benoît</creator><creator>Barbaud, Annick</creator><creator>Francès, Camille</creator><creator>Descamps, Vincent</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0001-6043-6242</orcidid></search><sort><creationdate>20201201</creationdate><title>Belimumab for refractory manifestations of cutaneous lupus: A multicenter, retrospective observational study of 16 patients</title><author>Salle, Romain ; Chasset, François ; Kottler, Diane ; Picard-Dahan, Catherine ; Jannic, Arnaud ; Mekki, Nour ; De Risi-Pugliese, Tullia ; Monfort, Jean-Benoît ; Barbaud, Annick ; Francès, Camille ; Descamps, Vincent</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c500t-254690d2129d39658f1f7555d3837c6ce6eb2eace692f5956e4fcd6ccff7af8c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antibodies, Monoclonal, Humanized - pharmacology</topic><topic>Antibodies, Monoclonal, Humanized - therapeutic use</topic><topic>Drug Resistance</topic><topic>Female</topic><topic>Humans</topic><topic>Immunosuppressive Agents - pharmacology</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Life Sciences</topic><topic>Lupus Erythematosus, Cutaneous - diagnosis</topic><topic>Lupus Erythematosus, Cutaneous - drug therapy</topic><topic>Lupus Erythematosus, Cutaneous - immunology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Severity of Illness Index</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salle, Romain</creatorcontrib><creatorcontrib>Chasset, François</creatorcontrib><creatorcontrib>Kottler, Diane</creatorcontrib><creatorcontrib>Picard-Dahan, Catherine</creatorcontrib><creatorcontrib>Jannic, Arnaud</creatorcontrib><creatorcontrib>Mekki, Nour</creatorcontrib><creatorcontrib>De Risi-Pugliese, Tullia</creatorcontrib><creatorcontrib>Monfort, Jean-Benoît</creatorcontrib><creatorcontrib>Barbaud, Annick</creatorcontrib><creatorcontrib>Francès, Camille</creatorcontrib><creatorcontrib>Descamps, Vincent</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salle, Romain</au><au>Chasset, François</au><au>Kottler, Diane</au><au>Picard-Dahan, Catherine</au><au>Jannic, Arnaud</au><au>Mekki, Nour</au><au>De Risi-Pugliese, Tullia</au><au>Monfort, Jean-Benoît</au><au>Barbaud, Annick</au><au>Francès, Camille</au><au>Descamps, Vincent</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Belimumab for refractory manifestations of cutaneous lupus: A multicenter, retrospective observational study of 16 patients</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2020-12-01</date><risdate>2020</risdate><volume>83</volume><issue>6</issue><spage>1816</spage><epage>1819</epage><pages>1816-1819</pages><issn>0190-9622</issn><eissn>1097-6787</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32439463</pmid><doi>10.1016/j.jaad.2020.05.058</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-6043-6242</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0190-9622 |
ispartof | Journal of the American Academy of Dermatology, 2020-12, Vol.83 (6), p.1816-1819 |
issn | 0190-9622 1097-6787 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_03492590v1 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adult Aged Antibodies, Monoclonal, Humanized - pharmacology Antibodies, Monoclonal, Humanized - therapeutic use Drug Resistance Female Humans Immunosuppressive Agents - pharmacology Immunosuppressive Agents - therapeutic use Life Sciences Lupus Erythematosus, Cutaneous - diagnosis Lupus Erythematosus, Cutaneous - drug therapy Lupus Erythematosus, Cutaneous - immunology Male Middle Aged Retrospective Studies Severity of Illness Index Treatment Outcome Young Adult |
title | Belimumab for refractory manifestations of cutaneous lupus: A multicenter, retrospective observational study of 16 patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T00%3A43%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Belimumab%20for%20refractory%20manifestations%20of%20cutaneous%20lupus:%20A%20multicenter,%20retrospective%20observational%20study%20of%2016%20patients&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Salle,%20Romain&rft.date=2020-12-01&rft.volume=83&rft.issue=6&rft.spage=1816&rft.epage=1819&rft.pages=1816-1819&rft.issn=0190-9622&rft.eissn=1097-6787&rft_id=info:doi/10.1016/j.jaad.2020.05.058&rft_dat=%3Celsevier_hal_p%3ES0190962220309233%3C/elsevier_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32439463&rft_els_id=S0190962220309233&rfr_iscdi=true |